Jaime Davidson, MD, FACP, MACE
Clinical Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism
University of Texas Southwestern Medical School
Dallas, TX
Clinical Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism
University of Texas Southwestern Medical School
Dallas, TX
Related Videos
What patients with T2D are most likely to benefit from fixed-ratio combinations such a iDegLira and iGlarLixi?
Can you provide a roadmap for how insulin plus GLP-1 RA combination formulations should be titrated?
Can you provide a roadmap for how insulin plus GLP-1 RA combination formulations should be titrated?
From a practical perspective, how should clinicians titrate the fixed-ratio combinations such a iDegLira and iGlarLixi?
What is the rationale for combining a basal insulin and GLP-1 RA in a fixed-ratio formulation?
What is the rationale for combining a basal insulin and GLP-1 RA in a fixed-ratio formulation?